Slavica Krantic

Dr. Slavica Krantic

Sorbonne University, St Antoine’s Research Center, INSERM UMRS 938, Paris, France

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2022 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
DBDiane Bairamian
Diane Bairamian
SSSha Sha
Sha Sha
NRNathalie Rolhion
Nathalie Rolhion
HSHarry Sokol
Harry Sokol
GDGuillaume Dorothée
Guillaume Dorothée
Slavica KranticSlavica Krantic
Slavica Krantic
Background: The implication of gut microbiota in the control of brain functions in health and disease is a novel, currently emerging concept. Accumulating data suggest that the gut microbiota exert its action at least in part by modulating neuroinflammation. Given the link between neuroinflammatory changes and neuronal activity, it is plausible that gut microbiota may affect neuronal functions indirectly by impacting microglia, a key player in neuroinflammation. Indeed, increasing evidence suggests that interplay between microglia and synaptic dysfunction may involve microbiota, among other factors. In addition to these indirect microglia-dependent actions of microbiota on neuronal activity, it has been recently recognized that microbiota could also affect neuronal activity directly by stimulation of the vagus nerve. Main messages: The putative mechanisms of the indirect and direct impact of microbiota on neuronal activity are discussed by focusing on Alzheimer’s disease, one of the most studied neurodegenerative disorders and the prime cause of dementia worldwide. More specifically, the mechanisms of microbiota-mediated microglial alterations are discussed in the context of the peripheral and central inflammation cross-talk. Next, we highlight the role of microbiota in the regulation of humoral mediators of peripheral immunity and their impact on vagus nerve stimulation. Finally, we address whether and how microbiota perturbations could affect synaptic neurotransmission and downstream cognitive dysfunction. Conclusions: There is strong increasing evidence supporting a role for the gut microbiome in the pathogenesis of Alzheimer’s disease, including effects on synaptic dysfunction and neuroinflammation, which contribute to cognitive decline. Putative early intervention strategies based on microbiota modulation appear therapeutically promising for Alzheimer’s disease but still require further investigation.

1 February 2007 in Progress in Neurobiology
Verified
Journal Article
Closed access
Slavica KranticSlavica Krantic
Slavica Krantic
NMNaguib Mechawar
Naguib Mechawar
SRStéphanie Reix
Stéphanie Reix
RQRémi Quirion
Rémi Quirion

1 November 2007 in Cell Cycle
Verified
Journal Article
Closed access
HBHanan Boujrad
Hanan Boujrad
OGOlena Gubkina
Olena Gubkina
NRNadine Robert
Nadine Robert
Slavica KranticSlavica Krantic
Slavica Krantic
SSSantos A. Susin
Santos A. Susin
Historically, two main forms of cell death have been distinguished: apoptosis and necrosis. Apoptosis was initially considered as the only physiological and programmed form of cell death. This type of death is recurrently associated with caspases, a family of cysteine proteases activated in apoptotic conditions. However, it is now widely recognized that programmed cell death (PCD) can also occur in the complete absence of caspase activation. The existence of non-caspase PCD pathways was corroborated by the discovery of caspase-independent executioners, such as the mitochondrial protein Apoptosis-Inducing Factor (AIF). Necrosis has often been viewed as an accidental and uncontrolled cell death process. Nevertheless, increasing evidence shows that, like apoptosis, necrosis could be a highly regulated type of PCD. Indeed, apoptosis and necrosis present more similarities than it has been originally thought. Here, we summarize the different classifications of PCD and the current knowledge of a necrotic PCD pat...

1 December 2005 in Trends in Neurosciences
Verified
Journal Article
Closed access
Slavica KranticSlavica Krantic
Slavica Krantic
NMNaguib Mechawar
Naguib Mechawar
SRStéphanie Reix
Stéphanie Reix
RQRémi Quirion
Rémi Quirion

1 December 2000 in Peptides
Verified
Journal Article
Closed access
Slavica KranticSlavica Krantic
Slavica Krantic

20 March 2012 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
Slavica KranticSlavica Krantic
Slavica Krantic
NINathalie Isorce
Nathalie Isorce
NMNaguib Mechawar
Naguib Mechawar
MDMaria Antonietta Davoli
Maria Antonietta Davoli
EVErika Vignault
Erika Vignault
RQRémi Quirion
Rémi Quirion
The relevance of γ-amino-butyric acid (GABA)-ergic dysfunctions in the pathology of Alzheimer's disease (AD) remains a matter of debate. In the present study, we characterized the toxicity of amyloid-β (Aβ) on hippocampal GABAergic neurons both in vi